Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic mesenchymal stem cells (Biocells Medical)
- Development stage
- Preclinical
- Lead developer
- Biocells Medical
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Allogeneic mesenchymal stem cells (MSCs) developed by Biocells Medical are an investigational cell therapy being evaluated for the treatment of complex neuroinflammatory conditions, including autoimmune encephalitis, early-stage panencephalitis, and neuroinflammatory demyelination. MSCs are multipotent stromal cells characterized by their potent immunomodulatory and regenerative properties. When administered intravenously, these cells migrate toward sites of tissue injury and inflammation, where they exert therapeutic effects through paracrine signaling. They secrete a broad array of bioactive molecules, including anti-inflammatory cytokines and growth factors, which modulate the activity of T-lymphocytes, B-lymphocytes, and microglia. This action aims to suppress aberrant immune responses, reduce neuroinflammation, and support the repair of the central nervous system in patients with autoinflammatory or post-infectious neurological syndromes.
- Other names
- Allogeneic MSCsAllogeneic MSC infusionsMesenchymal stem cells (Biocells Medical)
Beyond the preview
Go deeper on allogeneic mesenchymal stem cells (Biocells Medical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic mesenchymal stem cells (Biocells Medical).